mirror-biologics
(2)
Michael Har-Noy’s second invention: building a company
Michael Har-Noy moved from San Diego to Israel to build a business around his research. Two decades later, his story runs through manufacturing rooms, millions of frequent-flyer miles and the complicated business of founder control.
Elizabeth Czerepak
Elizabeth Czerepak is a life sciences finance executive with more than three decades in big pharma, venture capital, and public biotech. She is Chief Financial Officer and VP of Corporate Development at Mirror Biologics, a clinical-stage immunotherapy company in Wesley Chapel, Florida, where she also served as acting CEO from July 2024 to May 2025. Over her career she has helped raise hundreds of millions of dollars, taken companies public through IPOs and SPAC mergers, and worked on landmark pharma transactions including the search that led to BASF Pharma's sale to Abbott. She sits on the boards of Delcath Systems and TransCode Therapeutics.